MedPath

Anarica

Brand Name: Anarica

Generic Name: Pregabalin

Active
Registration Number

DR-XY45116

Dosage Form

Capsule

Issuance Date

January 27, 2021

Expiry Date

March 2, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength150 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PregabalinActive
Monograph: Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform